BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Aptiv Solutions Awarded Pivotal International Cancer Vaccine Trial

  September 28, 2011

   · 

  1 min read
• Deals

  Simulations Plus Bid for Assets of Entelos, Inc. Not Selected

  September 28, 2011

   · 

  1 min read
• Genetown

  Zafgen to Present at The Obesity Society 29th Annual Scientific Meeting

  September 28, 2011

   · 

  1 min read
• Drug Development

  Adamas Pharmaceuticals Initiates a Phase 2/3 Clinical Study of ADS-5102 for Parkinson’s Disease

  September 28, 2011

   · 

  4 min read
• Pharm Country

  Proteonomix, Inc. (PROT) Notes Progress Toward Clinical Trial of UMK-121

  September 28, 2011

   · 

  2 min read
• Policy

  Transcept Pharmaceuticals, Inc. Resubmits Intermezzo(R) NDA to FDA

  September 28, 2011

   · 

  1 min read
• Deals

  Teva Pharmaceutical Industries Limited Exec Says Cephalon, Inc. Deal is Still on Track

  September 28, 2011

   · 

  1 min read
• Policy

  Horizon Pharma, Inc. Submits New Drug Application for LODOTRA(R) for the Treatment of Rheumatoid Arthritis

  September 28, 2011

   · 

  6 min read
• Pharm Country

  Momenta Pharmaceuticals, Inc. and Gilead Sciences, Inc. Brace for More Competition

  September 28, 2011

   · 

  2 min read
• Deals

  Graceway Pharmaceuticals, LLC Reaches Agreement to Sell its Assets to Galderma Pharma S.A. for Undisclosed Amount

  September 28, 2011

   · 

  2 min read